Showing results (21-30 of 74) with videos related to
Sort By:
Pageof 8
Cancer Detection and Prevention|December 29, 2000
17 alpha androstenediol inhibition of breast tumor cell proliferation in estrogen receptor-positive and -negative cell linesP N Huynh, W H Carter, R M LoriaBiometrics|September 1, 1980
Survival analysis of drug combinations using a hazards model with time-dependent covariatesD M Stablein, W H Carter, G L WamplerBiometrics|September 1, 1983
Confidence regions for constrained optima in response-surface experimentsD M Stablein, W H Carter, G L WamplerCancer|August 1, 1984
Solid tumor models for the assessment of different treatment modalities. XXII. The alternate utilization of radiotherapy and chemotherapyW B Looney, H A Hopkins, W H CarterJournal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft diseaseR C Hard, W H Carter, P H BickOptics Letters|September 12, 2009
Resistance of holograms made in Polaroid DMP128 photopolymer to ionizing radiation damageJ P Golden, G P Summers, W H CarterJournal of Dental Research|April 1, 1978
The determination of antibody to Streptococcus mutans serotypes in saliva for children ages 3 to 7 yearsD L Everhart, K Rothenberg, W H Carter, et al.Biometrics|September 1, 1990
Interpreting plots of a multidimensional dose-response surface in a parallel coordinate systemC Gennings, K S Dawson, W H Carter, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1984
Potentiation of narcotic-induced antinociception by tripelennamine in morphine-tolerant and drug-naive miceE Tagashira, J F Kachur, W H Carter, et al.Cancer Treatment Reports|August 1, 1977
On determining the levels of treatment to optimize the probability of a favorable responseW H Carter, G L Wampler, S L Crews, et al.Pageof 8